An opinion piece argues that while recent federal moves to advance psychedelic research represent progress, they are contradicted by concurrent policy choices that undermine the social foundations necessary for sustained recovery from mental health conditions and addiction.
President Trump signed an executive order advancing psychedelic therapies, with support from prominent Republicans including former Texas Governor Rick Perry, who has championed ibogaine as a revolutionary treatment for veterans and others suffering from trauma and addiction. Republican lawmakers including Dan Crenshaw and Morgan Luttrell of Texas and Jack Bergman of Michigan have introduced legislation directing the Department of Defense and Department of Veterans Affairs to study psychedelic compounds for PTSD, traumatic brain injury, and addiction.
However, research consistently demonstrates that the strongest predictors of sustained recovery from addiction are social support and recovery capital—stable housing, employment opportunities, access to health care, supportive family relationships, and communities that enable recovery. These social conditions are as critical as pharmacological treatment.
The authors note that the Republican budget framework known as the “One Big Beautiful Bill” will cut more than $1 trillion from federal programs including Medicaid and food assistance over the coming decade. These programs fund addiction treatment, mental health care, housing stability, and basic economic security. The contradiction is particularly stark for veterans: while lawmakers invoke psychedelic research as a lifeline for veterans with PTSD or traumatic brain injury, the same political agenda weakens the safety net veterans depend on—health care services, housing support, food security, and community-based behavioral health systems.
Decades of research show that exclusion driven by economic inequality, social marginalization, or barriers tied to race, class, or gender contributes to psychological distress and substance use. The same conditions that push people to society’s margins often make recovery harder. Without reinvestment in housing, healthcare, community mental health systems, long-term therapeutic relationships, and economic stability, delivering pharmacological solutions risks abandoning people to the same difficult conditions that generated their suffering.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.statnews.com/2026/04/20/trump-executive-order-psychedelics-republicans-veterans-ibogaine/